Eli Lilly's Tirzepatide Shows Promising Results in Sleep Apnea Treatment, Justifying a Buy Rating

Retrieved on: 2024-06-22 19:47:55

Tags for this article:

Sleep disorders

Peptide hormones

PEPTIDE THERAPEUTICS

LLY

Eli Lilly and Company

Sleep apnea

Continuous positive airway pressure

Click the tags to see associated articles and topics

Eli Lilly's Tirzepatide Shows Promising Results in Sleep Apnea Treatment, Justifying a Buy Rating. View article details on hiswai:

Excerpt

These factors combined with the strategic importance of the sleep apnea indication in expanding drug use, as identified in Wells Fargo's Obesity Deep- ...

Article found on: markets.businessinsider.com

View Original Article